Cloudbreak Pharma Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
61
- Stock Symbol
-
02592
- Share Price
-
$0.15
- (As of Wednesday Closing)
Cloudbreak Pharma General Information
Description
Cloudbreak Pharma Inc is engaged in research and development of ophthalmology biotechnology. The company is a clinical-stage ophthalmology biotechnology company focused on developing treatments for ophthalmic diseases through the proprietary drug discovery and development capabilities, with operations based in the United States and China. The pipeline currently consists of nine drug candidates targeted for treatment of anterior and posterior ophthalmic diseases, including five clinical-stage and four pre-clinical stage candidates. The drugs in the pipeline include CBT-001, CBT-004, CBT-009, and CBT-199.
Contact Information
Website
www.cloudbreakpharma.comCorporate Office
- 8921 Research Drive
- Irvine, CA 92618
- United States
Corporate Office
- 8921 Research Drive
- Irvine, CA 92618
- United States
Cloudbreak Pharma Stock Performance
As of 09-Sep-2026, Cloudbreak Pharma’s stock price is $0.15. Its current market cap is $140M with 925M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.15 | $0.15 | $0.11 - $1.23 | $140M | 925M | 316K | -$0.15 |
Cloudbreak Pharma Financials Summary
As of 30-Jun-2026, Cloudbreak Pharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 118,023 | 536,494 | ||
| Revenue | 0 | 0 | 10,000 | 0 |
| EBITDA | (121,446) | (68,294) | (99,067) | (132,163) |
| Net Income | (120,793) | (67,660) | (99,130) | (129,418) |
| Total Assets | 54,138 | 66,608 | 40,009 | 64,831 |
| Total Debt | 6,428 | 762 | 511 | 545 |
Cloudbreak Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cloudbreak Pharma Comparisons
Industry
Financing
Details
Cloudbreak Pharma Competitors (12)
One of Cloudbreak Pharma’s 12 competitors is Opus Genetics, a Formerly VC-backed company based in Durham, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Opus Genetics | Formerly VC-backed | Durham, NC | ||||
| Clearside Biomedical | Formerly VC-backed | Alpharetta, GA | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Kodiak Sciences | Formerly VC-backed | Palo Alto, CA |
Cloudbreak Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cloudbreak Pharma Patents
Cloudbreak Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023141207-A1 | Esters of 8-methyl-8-azabicyclo[3.2.1] octan-3-yl 3-hydroxy-2-phenylpropanoate | Inactive | 21-Jan-2022 | ||
| AU-2020346812-A1 | Methods for alleviating pterygium-associated worry about eye appearance | Inactive | 10-Sep-2019 | ||
| AU-2026202351-A1 | Methods for alleviating pterygium-associated worry about eye appearance | Pending | 10-Sep-2019 | ||
| CA-3146811-A1 | Methods for alleviating pterygium-associated worry about eye appearance | Pending | 10-Sep-2019 | ||
| EP-4027997-A2 | Methods for alleviating pterygium-associated worry about eye appearance | Pending | 10-Sep-2019 | A61K31/496 |
Cloudbreak Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cloudbreak Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Cloudbreak Pharma FAQs
-
When was Cloudbreak Pharma founded?
Cloudbreak Pharma was founded in 2015.
-
Where is Cloudbreak Pharma headquartered?
Cloudbreak Pharma is headquartered in Irvine, CA.
-
What is the size of Cloudbreak Pharma?
Cloudbreak Pharma has 61 total employees.
-
What industry is Cloudbreak Pharma in?
Cloudbreak Pharma’s primary industry is Drug Discovery.
-
Is Cloudbreak Pharma a private or public company?
Cloudbreak Pharma is a Public company.
-
What is Cloudbreak Pharma’s stock symbol?
The ticker symbol for Cloudbreak Pharma is 02592.
-
What is the current stock price of Cloudbreak Pharma?
As of 09-Sep-2026 the stock price of Cloudbreak Pharma is $0.15.
-
What is the current market cap of Cloudbreak Pharma?
The current market capitalization of Cloudbreak Pharma is $140M.
-
Who are Cloudbreak Pharma’s competitors?
Opus Genetics, Clearside Biomedical, AbbVie, Regenxbio, and Kodiak Sciences are some of the 12 competitors of Cloudbreak Pharma.
-
What is Cloudbreak Pharma’s annual earnings per share (EPS)?
Cloudbreak Pharma’s EPS for 12 months was -$0.15.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
